We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
+$546M
Cap. Flow
+$263M
Cap. Flow %
4.63%
Top 10 Hldgs %
11.85%
Holding
1,134
New
196
Increased
491
Reduced
251
Closed
159

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$35.7M
2
MRK icon
Merck
MRK
+$30.3M
3
MSFT icon
Microsoft
MSFT
+$22.4M
4
YUMC icon
Yum China
YUMC
+$17.6M
5
OXY icon
Occidental Petroleum
OXY
+$17.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$36.5M
2
INTC icon
Intel
INTC
+$32.4M
3
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$17.1M
4
NVR icon
NVR
NVR
+$16.3M
5
DE icon
Deere & Co
DE
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.48%
2 Financials 17.92%
3 Industrials 13.48%
4 Consumer Discretionary 11.28%
5 Healthcare 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYNC
901
DELISTED
Synacor, Inc.
SYNC
$208K ﹤0.01%
90,367
+39,399
+77% +$97.9K
CCXI
902
DELISTED
ChemoCentryx, Inc.
CCXI
$207K ﹤0.01%
34,808
-84,913
-71% -$583K
INSG icon
903
Inseego
INSG
$108M
$205K ﹤0.01%
12,710
-1,460
-10% -$22.7K
MSCI icon
904
MSCI
MSCI
$40B
$201K ﹤0.01%
1,590
-20,975
-93% -$2.62M
AE
905
DELISTED
Adams Resources & Energy Inc
AE
$201K ﹤0.01%
4,617
-400
-8% -$17.8K
LHCG
906
DELISTED
LHC Group LLC
LHCG
$200K ﹤0.01%
3,270
-3,120
-49% -$206K
PTCT icon
907
PTC Therapeutics
PTCT
$6.37B
$198K ﹤0.01%
+11,850
New +$201K
OMED
908
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$198K ﹤0.01%
48,400
+6,600
+16% +$28.7K
DCOY
909
Decoy Therapeutics
DCOY
$2.68M
– –
0
– –
TPST icon
910
Tempest Therapeutics
TPST
$14.8M
$195K ﹤0.01%
+48
New +$201K
IMBI
911
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$195K ﹤0.01%
13,925
– –
KODK icon
912
Kodak
KODK
$806M
$194K ﹤0.01%
62,717
+37,788
+152% +$175K
STML
913
DELISTED
Stemline Therapeutics, Inc.
STML
$193K ﹤0.01%
+12,360
New +$165K
JNP
914
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$191K ﹤0.01%
39,301
+1,000
+3% +$4.86K
ALTO icon
915
Alto Ingredients
ALTO
$360M
$188K ﹤0.01%
+41,300
New +$196K
TNDM icon
916
Tandem Diabetes Care
TNDM
$1.17B
$186K ﹤0.01%
78,886
+55,001
+230% +$173K
CLUB
917
DELISTED
Town Sports International Holdings, Inc.
CLUB
$180K ﹤0.01%
32,480
+331
+1% +$2.04K
ASPN icon
918
Aspen Aerogels
ASPN
$387M
$179K ﹤0.01%
36,700
+5,300
+17% +$24.7K
PTX
919
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$176K ﹤0.01%
73,421
+11,700
+19% +$32.4K
ICAD
920
DELISTED
iCAD Inc
ICAD
$175K ﹤0.01%
50,914
+24
+0% +$97
EGC
921
DELISTED
Energy XXI Gulf Coast, Inc. Common Stock
EGC
$173K ﹤0.01%
+30,061
New +$212K
DRRX
922
DELISTED
DURECT Corp
DRRX
$172K ﹤0.01%
18,647
+13,348
+252% +$159K
PLUR icon
923
Pluri
PLUR
$19.2M
$172K ﹤0.01%
1,558
+1,371
+733% +$171K
CGRN
924
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$172K ﹤0.01%
22,387
-2,979
-12% -$26.5K
OREX
925
DELISTED
Orexigen Therapeutics, Inc.
OREX
$172K ﹤0.01%
133,658
+42,119
+46% +$68.6K
35 36
37
38 39

Similar funds

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management's Q4 2017 Portfolio in Review

As of Q4 2017, Jacobs Levy Equity Management held 1,134 positions worth $5.69B, up 11% from $5.14B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jacobs Levy Equity Management deployed $263M of net new capital in Q4 2017, opening 196 new positions and adding to 491 existing holdings. Its largest new stake was Yum China: 427,927 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $36.5M trimmed.

  • Jacobs Levy Equity Management's largest Q4 2017 buy was Yum China: 427,927 shares worth $17.1M.
  • Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q4 2017, an estimated $35.7M increase.
  • Jacobs Levy Equity Management's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $36.5M.
  • Jacobs Levy Equity Management fully exited Twenty-First Century Fox, Inc. Class A in Q4 2017, selling an estimated $17.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.69B portfolio in Q4 2017.
  • Jacobs Levy Equity Management opened 196 new positions and closed 159 in Q4 2017.
  • Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $5.69B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2017, filed 13 Feb 2018.